Category Archives: News

HepC and HIV News from around the world

Can Statin Therapy Reduce Heart Disease Risk in HIV- Positive People?

Current_Research_and_Opinions_200An important study called REPRIEVE, aims to answer some important questions regarding heart disease risk for people living with HIV. The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), or A5332, is a multi-centered, mainly US based, study is investigating the use of prophylactic statin therapy as a preventative method against cardiovascular disease (CVD) in HIV-positive people. REPRIEVE is one of the largest prospective interventional studies to be conducted among HIV patients, and the first major study to widely test a prevention strategy for cardiovascular disease in the HIV population. If successful, the prophylactic use of statins could provide an important means of significantly reducing the occurrence of heart disease in the HIV-positive population.

Continue reading Can Statin Therapy Reduce Heart Disease Risk in HIV- Positive People?

HIV in the Latino Community on the Rise

Current_Research_and_Opinions_200HIV among the Latino community is on the rise with Latinos representing 21% of all new HIV infections, yet only 13% of the U.S. population. It is estimated that 23% of the 1.2 million people living with HIV in the United States in 2012 were Latinos. The rate of HIV infection in Latinos is more than three times that of non- Hispanic whites. Latino’s are usually in later stages of HIV disease when diagnosed and experience significant barriers to treatment. The CDC reports that 54.8% of Latinos living with HIV are retained in treatment with 43.3% prescribed antiretroviral treatment and 35.6% achieving viral suppression. Risk factors attributed to Latinos are intravenous drug use, multiple sexual partners and male- to- male transmission.

Continue reading HIV in the Latino Community on the Rise

CVD in HIV Patients

Current_Research_and_Opinions_200Antiretroviral therapy has dramatically increased the life span of HIV patients. Despite this, people living with HIV experience other devastating illnesses, such as cardiovascular disease (CVD), at a significant rate. Cardiovascular diseases and related conditions often seen in people living with HIV include coronary artery disease, heart attack, pulmonary hypertension, heart failure and stroke.

Continue reading CVD in HIV Patients

HIV drug used to reverse effects of virus that causes cervical cancer

HIV News LogoA commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.

Drs Ian and Lynne Hampson, from the University’s Institute of Cancer Sciences and Dr Innocent Orora Maranga, Consultant in Obstetrics and Gynaecology at KNH in Nairobi examined Kenyan women diagnosed with HPV positive early stage cervical cancer who were treated with the antiviral HIV drug lopinavir in Kenya.
Continue reading HIV drug used to reverse effects of virus that causes cervical cancer

Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance

HCV News LogoMore than 100 Walgreens Pharmacies Designated Hepatitis C-Specialized to Meet Projected Patient Care Management Needs and Improve Medication Adherence.

With new advances in treatment therapy now available for hepatitis C patients, Walgreens (NYSE:WAG) (Nasdaq:WAG) today announced it is expanding access to Walgreens Connected Caresm hepatitis C program through its more than 100 hepatitis C-specialized pharmacies. Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence.
Continue reading Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance